These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30593183)

  • 1. Transcutaneous auricular vagus nerve stimulation in treating major depressive disorder: A systematic review and meta-analysis.
    Wu C; Liu P; Fu H; Chen W; Cui S; Lu L; Tang C
    Medicine (Baltimore); 2018 Dec; 97(52):e13845. PubMed ID: 30593183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: A nonrandomized controlled pilot study.
    Rong P; Liu J; Wang L; Liu R; Fang J; Zhao J; Zhao Y; Wang H; Vangel M; Sun S; Ben H; Park J; Li S; Meng H; Zhu B; Kong J
    J Affect Disord; 2016 May; 195():172-9. PubMed ID: 26896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
    Tan C; Qiao M; Ma Y; Luo Y; Fang J; Yang Y
    J Affect Disord; 2023 Sep; 337():37-49. PubMed ID: 37230264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial.
    Wang L; Zhang J; Guo C; He J; Zhang S; Wang Y; Zhao Y; Li L; Wang J; Hou L; Li S; Wang Y; Hao L; Zhao Y; Wu M; Fang J; Rong P
    Brain Stimul; 2022; 15(6):1405-1414. PubMed ID: 36150665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous auricular vagus nerve stimulators: a review of past, present, and future devices.
    Wang L; Wang Y; Wang Y; Wang F; Zhang J; Li S; Wu M; Li L; Rong P
    Expert Rev Med Devices; 2022 Jan; 19(1):43-61. PubMed ID: 34937487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder: A Randomized Trial.
    Li S; Rong P; Wang Y; Jin G; Hou X; Li S; Xiao X; Zhou W; Wu Y; Liu Y; Zhang Y; Zhao B; Huang Y; Cao J; Chen H; Hodges S; Vangel M; Kong J
    Neuromodulation; 2022 Apr; 25(3):450-460. PubMed ID: 35088753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate modulatory effects of transcutaneous auricular vagus nerve stimulation on the resting state of major depressive disorder.
    Sun J; Guo C; Ma Y; Gao S; Luo Y; Chen Q; Hong Y; Hou X; Xiao X; Yu X; Rong P; Fang J
    J Affect Disord; 2023 Mar; 325():513-521. PubMed ID: 36642310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous auricular vagus nerve stimulation for epilepsy.
    Zhang Q; Luo X; Wang XH; Li JY; Qiu H; Yang DD
    Seizure; 2024 Jul; 119():84-91. PubMed ID: 38820674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary single-arm study of brain effects during transcutaneous auricular vagus nerve stimulation treatment of recurrent depression by resting-state functional magnetic resonance imaging.
    Limei C; Jifei S; Chunlei G; Xiaojiao LI; Zhi W; Yang H; Jiliang F
    J Tradit Chin Med; 2022 Oct; 42(5):818-824. PubMed ID: 36083491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying antidepressant effect of transcutaneous auricular vagus nerve stimulation on CUMS model rats based on hippocampal α7nAchR/NF-κB signal pathway.
    Wang JY; Zhang Y; Chen Y; Wang Y; Li SY; Wang YF; Zhang ZX; Zhang J; Rong P
    J Neuroinflammation; 2021 Dec; 18(1):291. PubMed ID: 34920740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis.
    Kim AY; Marduy A; de Melo PS; Gianlorenco AC; Kim CK; Choi H; Song JJ; Fregni F
    Sci Rep; 2022 Dec; 12(1):22055. PubMed ID: 36543841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the modulating effect of transcutaneous auricular vagus nerve stimulation on voxel-based analyses in patients with first-episode major depressive disorder: a resting-state functional magnetic resonance imaging study.
    He JK; Li SY; Wang Y; Zhao B; Xiao X; Hou XB; Zhang S; Zhao YN; Zhai WH; Fang JL; Rong PJ
    Braz J Psychiatry; 2023 May; 45(2):93-101. PubMed ID: 37015869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural, Anti-Inflammatory, and Clinical Effects of Transauricular Vagus Nerve Stimulation in Major Depressive Disorder: A Systematic Review.
    Parente J; Carolyna Gianlorenco A; Rebello-Sanchez I; Kim M; Mario Prati J; Kyung Kim C; Choi H; Song JJ; Fregni F
    Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 37870480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive study of the efficacy of transcutaneous auricular vagus nerve stimulation in the treatment of major depressive disorder: An fMRI-based machine learning analysis.
    Sun J; Sun K; Chen L; Li X; Xu K; Guo C; Ma Y; Cao J; Zhang G; Hong Y; Wang Z; Gao S; Luo Y; Chen Q; Ye W; Yu X; Xiao X; Rong P; Yu C; Fang J
    Asian J Psychiatr; 2024 Aug; 98():104079. PubMed ID: 38838458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of transcutaneous auricular vagus nerve stimulation on functional connectivity in the related brain regions of patients with depression based on the resting-state fMRI].
    Ma Y; Guo CL; Sun JF; Gao SS; Luo Y; Chen QY; Hong Y; Zhang L; Cao JD; Xiao X; Rong PJ; Fang JL
    Zhongguo Zhen Jiu; 2023 Apr; 43(4):367-73. PubMed ID: 37068810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous Auricular Vagus Nerve Stimulation Combined With Slow Breathing: Speculations on Potential Applications and Technical Considerations.
    Szulczewski MT
    Neuromodulation; 2022 Apr; 25(3):380-394. PubMed ID: 35396070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study.
    Yi S; Wang Z; Yang W; Huang C; Liu P; Chen Y; Zhang H; Zhao G; Li W; Fang J; Liu J
    Front Neurosci; 2022; 16():1018387. PubMed ID: 36312012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder with peripartum onset: A multicenter, open-label, controlled proof-of-concept clinical trial (DELOS-1).
    Deligiannidis KM; Robakis T; Homitsky SC; Ibroci E; King B; Jacob S; Coppola D; Raines S; Alataris K
    J Affect Disord; 2022 Nov; 316():34-41. PubMed ID: 35932937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No modulation of pupil size and event-related pupil response by transcutaneous auricular vagus nerve stimulation (taVNS).
    Keute M; Demirezen M; Graf A; Mueller NG; Zaehle T
    Sci Rep; 2019 Aug; 9(1):11452. PubMed ID: 31391505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.